You are here

Our Team

Dr. Monika Bahl, MBBS, MBA, Director Clinical Portfolio Management

http://www.cdsaindia.in/sites/default/files/monika.png

Dr. Monika has joined CDSA as the Director Clinical Portfolio Management. A graduate in medicine with additional specialization in human resource management, she brings with her over 16 years of experience in clinical practice and clinical research including project planning, clinical monitoring and project management for in-house and outsourced clinical research projects. She has substantial experience of managing projects in varied therapeutic indications including immunology, pain management, cardiovascular, respiratory, dermatology, psychiatry and diabetes mellitus in previous assignments in Indian and global pharmaceutical / Biotech industry (Ranbaxy Research Laboratories, Dabur Research Foundation, Panacea Biotec, Quintiles).  

She has been associated with clinical studies in paediatric, adult and geriatric populations including mega-trials for DCGI/FDA/BfArM submissions. Her responsibilities have spanned from project planning, protocol designing, CRO selection and project management for the full duration of studies from pre-trial to project close-out, medical monitoring, data review and related medical writing. She has significantly contributed to training and mentoring programs for performance improvement and for quality management initiatives on individual, project and organizational level.

Dr. Sucheta Banerjee Kurundkar, PhD (Biochemistry), MBA, Director Training

http://www.cdsaindia.in/sites/default/files/sucheta%20final%20pic.jpg

Dr. Sucheta Banerjee Kurundkar has joined CDSA as Director Training in 2012. She has 19 years of experience in various capacities in research & CRO Industry. In her last assignment, she was Chief Scientific Officer at a multinational Clinical Research Organization. Sucheta has worked for several years in the area of Quality Assurance in pre-clinical, clinical and medical laboratories and has an avid interest in this area. She is a GLP Trainer (WHO); Auditor for NABL (ISO 15189 & ISO 17025) & NABH. Sucheta has a Ph.D. in Biochemistry from University of Pune and her doctoral work on a novel inhibitor received recognition at the World Congress on Insulin Resistance Diabetes & Cardiovascular Research, USA. She has completed Management Development Program in Advanced Quality Management from IIM, Ahmedabad and Management of Training from Institute of Secretariat Training and Management, New Delhi. She completed her MBA with specialization in Total Quality Management from SMU. Sucheta is reviewer to ten International Journals of repute. She is the recipient of CSIR International Travel Award (2010). At CDSA, she has been involved in the conduct of ~100 training programs across ~50 cities involving ~6000 participants, ~1700 institutions and ~900 faculty members.

Dr. Pawandeep Kaur, MBBS, MD (Pharmacology), Associate Medical Director

Dr. Pawandeep Kaur has joined CDSA as Associate Medical Director. A post graduate in Medicine (MD, Pharmacology) she has over 10 years of experience in professing clinical research, clinical practice and as clinical research scientist. She has started her career as Junior resident at Govt. Medical College, Patiala and then as Demonstrator in Anatomy at DMCH, Ludhiana. After her MD in Pharmacology from Govt Medical College, Amritsar; She worked as Clinical Pharmacologist at Escorts Heart Institute and Research Centre, Delhi where she also played a role of member of Institutional Review Board and member secretary of various hospital committees. Before moving to Pharma Industry she worked as Assistant Professor in Institute of Clinical Research India and mentored students for various research projects of Cranfield University, UK. Dr. Pawandeep brings forth good amount of experience in the field of clinical research and development. She has played a crucial role in the development of new drug – through clinical phases and all the way to commercialization. In the process, Her responsibilities have traversed from protocol designing, writing clinical study reports, new drug application and other regulatory documents as well as medical monitoring of clinical trials to ensure GCP compliance. She had been felicitated along with other scientists by Ex-President Dr. APJ Abdul Kalam for her outstanding contribution in development of new drug for malaria. She had presented and published research papers at national and international conferences and journals. A fellow of American College of Clinical Pharmacology, she is also a member of Cochrane Breast Cancer Group, Sydney and Cochrane Back Review Group (CBRG), Toronto.

Prashant Bhujbal, Finance Manager

http://www.cdsaindia.in/sites/default/files/prashant.pngMr.Prashant Bhujbal has joined CDSA as Finance Manager. He did MBA in Finance and also holds a post graduate degree in Agriculture. He has worked for more than 23 years in the Maharashtra Finance and Account Cadre under Government of Maharashtra. As a member of finance Cadre he served on diverse postings in various Government departments ranging from Account, Audit and Procurement of Goods.

 

 

Sanjeeva Kumar, Administrative Manager

http://www.cdsaindia.in/sites/default/files/prashant.png

Sanjeeva Kumar joined CDSA as an Administrative Manager. With a Post-Graduate degree in Human Resource Management from Osmania University, Hyderabad. Sanjeeva has about 15 years of work experience in Human Resource Management & Administration across Infrastructure, Media & Power Sector. 

 

 
 

Dr.T.S.RAO, Sr. Adviser Vaccinology and Medical Technologies

Dr. T.S. Rao is a former Senior Adviser (Additional Secretary Rank) in the Department of Biotechnology (DBT), Ministry of Science and Technology, Govt. of India. Dr. Rao was associated with DBT for the past 27 years (since its inception) and coordinated programmes related to Medical Biotechnology, specially development of new and improved vaccines through Indo-US Vaccine Action Programme, Jai Vigyan Mission on vaccines, Vaccine Grand Challenge,  Human Genetics and Genome Analysis, International coordination programmes. Associated with development of cost effective Rotaviral diarrhoea vaccine ( ROTAVAC, $ 1/ dose).
 
Dr. Rao was also involved in establishment of DBT’s various autonomous institutions including two vaccine production units, BIBCOL & IVCOL, NBRC, THSTI (VIDRC, PBC, CBD, DDRC, CHME & CDSA), INSTEM (CCBT, CNS & C-CAMP), two Biotech Science Clusters, NCR Faridabad & B-LIFE, Bangaluru.
 
Dr. Rao has about 22 scientific publications and popular articles to his credit in national and international peer reviewed Journals (LANCET, VACCINE, NATURE GENETICS etc.). Dr. Rao was awarded the ‘Distinguished Services Award’ during the 5th Annual USA India Business Summit (UIBS), Atlanta and also recipient of PRATIBHA PURASKAR from A.P.
 
Since May, 2015, Dr. Rao, has been associated with CDSA as Sr. Adviser  for imparting his expertise in the field of vaccinology and Medical technologies etc.
 
Arun Kumar B. Ramteke, Consultant, Regulatory Affairs

http://www.cdsaindia.in/sites/default/files/arunm.pngMr. Ramteke retired as a senior drug regulatory officer with 31 years of experience in drug regulatory aspects in the office of the Drugs Controller General of India (DCGI). He has in-depth knowledge of Indian Drugs & Cosmetics Act, Rules and of regulations of Global Drug Regulatory norms. He started his career at Central Research Institute Kasauli in biological-drug testing. He has extensive experience with new drugs, vaccines and biotech products/pharmaceuticals, medical devices approvals and development experience. He also has experience in review and evaluation of product dossier for pre-clinical, toxicological, pharmacological, CMC, and quality control, clinical trial data of new drugs, biological and medical devices (INDs, ANDAs).

He has strong skills in quality assurance management, regulatory oversight of clinical trials, development of SOPs and guidelines and involvement in drug rules amendments. As an expert he has attended various national and international training workshops and meetings on drug regulations. He has contributed to preparation and implementation of Good Clinical Practices (GCP), Good Laboratory Practices (GLP) and Good Manufacturing Practices. He works as an Expert to the Pharmacovigilance Program, GCP Training and Inspections of CROs in India.